<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002863'>Myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SMD</z:e>) were studied in 58 patients (37 men, 21 women; mean age 61 years, range 18-81) who were grouped according to FAB criteria (Table 1) </plain></SENT>
<SENT sid="1" pm="."><plain>None of them showed a secondary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SMD</z:e> to medullary toxic agents or <z:chebi fb="0" ids="35610">cytostatic</z:chebi> treatments although 5 presented concomitant <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">neoplastic disease</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Morphologic alterations in peripheral blood smears and bone marrow were registered by 3 hematologists working independently </plain></SENT>
<SENT sid="3" pm="."><plain>The intracellular and extracellular iron deposits were evaluated in every case with Perls; peroxidase activity was determined in 16 patients and intraleucocitary alkaline phosphatase reaction was carried out in 17 patients </plain></SENT>
<SENT sid="4" pm="."><plain>Twenty five patients (43%) had <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> (RA); 10 (17%) <z:hpo ids='HP_0001924'>sideroblastic anemia</z:hpo>; 13 (25%) <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess of blasts (AREB); 3 (5%) AREB in transformation (AREB-T) and 7 myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (LMMC) </plain></SENT>
<SENT sid="5" pm="."><plain>Clinical manifestations at diagnosis are described in Table 2 </plain></SENT>
<SENT sid="6" pm="."><plain>In the observation period there were cases of <z:hpo ids='HP_0001903'>anemia</z:hpo> requiring transfusion, <z:mp ids='MP_0001794'>bacterial</z:mp> <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e>, muco-<z:mp ids='MP_0011514'>cutaneous hemorrhage</z:mp> and hemorrhagic episodes in the central <z:mp ids='MP_0008912'>nervous</z:mp> system </plain></SENT>
<SENT sid="7" pm="."><plain>In the bone marrow smears the cellularity was <z:mpath ids='MPATH_458'>normal</z:mpath> or increased in 53 cases and diminished in only 3 </plain></SENT>
<SENT sid="8" pm="."><plain>The degree of dysplastic characteristics (erythroid, granulocytic and megakaryocytic) ranged from low to severe </plain></SENT>
<SENT sid="9" pm="."><plain>It was low in most of AR, being the erythroid population the most affected in AS and the granulocytic one in AREB and AREB-T </plain></SENT>
<SENT sid="10" pm="."><plain>Patients with LMMC showed similar characteristics to those with myeloproliferative syndromes and the differential diagnosis were sometimes difficult, accounting for their separate inclusion in Table 4 </plain></SENT>
<SENT sid="11" pm="."><plain>Out of 23 patients, 5 presented clonal pathology detected in cytogenetic studies.(ABSTRACT TRUNCATED AT 250 WORDS) </plain></SENT>
</text></document>